These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 27911335)

  • 21. Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy.
    Barber BJ; Andrews JG; Lu Z; West NA; Meaney FJ; Price ET; Gray A; Sheehan DW; Pandya S; Yang M; Cunniff C
    J Pediatr; 2013 Oct; 163(4):1080-4.e1. PubMed ID: 23866715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UK physicians' attitudes and practices in long-term non-invasive ventilation of Duchenne Muscular Dystrophy.
    Kinali M; Manzur AY; Mercuri E; Gibson BE; Hartley L; Simonds AK; Muntoni F
    Pediatr Rehabil; 2006; 9(4):351-64. PubMed ID: 17111551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compliance to DMD Care Considerations in the Netherlands.
    Heutinck L; Houwen-van Opstal SLS; Krom YD; Niks EH; Verschuuren JJGM; Jansen M; de Groot IJM
    J Neuromuscul Dis; 2021; 8(6):927-938. PubMed ID: 34120911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulation disorders in Duchenne muscular dystrophy? Results of a registry-based online survey.
    Schorling DC; Müller CK; Pechmann A; Borell S; Langer T; Thiele S; Walter MC; Zieger B; Kirschner J
    Acta Myol; 2020 Mar; 39(1):2-12. PubMed ID: 32607473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and bother of patient-reported lower urinary tract symptoms in the muscular dystrophies.
    Bertrand LA; Askeland EJ; Mathews KD; Erickson BA; Cooper CS
    J Pediatr Urol; 2016 Dec; 12(6):398.e1-398.e4. PubMed ID: 27567595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of Health-Related Quality of Life in boys with Duchenne muscular dystrophy from six European countries.
    Otto C; Steffensen BF; Højberg AL; Barkmann C; Rahbek J; Ravens-Sieberer U; Mahoney A; Vry J; Gramsch K; Thompson R; Rodger S; Bushby K; Lochmüller H; Kirschner J
    J Neurol; 2017 Apr; 264(4):709-723. PubMed ID: 28175989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry.
    Cowen L; Mancini M; Martin A; Lucas A; Donovan JM
    BMC Neurol; 2019 May; 19(1):84. PubMed ID: 31046703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-reported quality of life and depressive symptoms in children, adolescents, and adults with Duchenne muscular dystrophy: a cross-sectional survey study.
    Elsenbruch S; Schmid J; Lutz S; Geers B; Schara U
    Neuropediatrics; 2013 Oct; 44(5):257-64. PubMed ID: 23794445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corticosteroid Treatments in Males With Duchenne Muscular Dystrophy: Treatment Duration and Time to Loss of Ambulation.
    Kim S; Campbell KA; Fox DJ; Matthews DJ; Valdez R;
    J Child Neurol; 2015 Sep; 30(10):1275-80. PubMed ID: 25414237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Survey of the actual state of medical care of patients with Duchenne muscular dystrophy in Japan].
    Matsumura T; Komaki H; Kawai M
    Rinsho Shinkeigaku; 2015; 55(9):637-45. PubMed ID: 26156259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of medical management for patients with Duchenne muscular dystrophy in Japan: what was changed by a practical guideline].
    Matsumura T; Komaki H
    Rinsho Shinkeigaku; 2019 Nov; 59(11):723-729. PubMed ID: 31656267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asthma control and differences in management practices across seven European countries.
    Vermeire PA; Rabe KF; Soriano JB; Maier WC
    Respir Med; 2002 Mar; 96(3):142-9. PubMed ID: 11905548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nutrition Considerations in Duchenne Muscular Dystrophy.
    Davis J; Samuels E; Mullins L
    Nutr Clin Pract; 2015 Aug; 30(4):511-21. PubMed ID: 25977513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of β
    Kelley EF; Cross TJ; Snyder EM; McDonald CM; ; Hoffman EP; Bello L
    Respir Res; 2019 Oct; 20(1):221. PubMed ID: 31619245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compliance to Care Guidelines for Duchenne Muscular Dystrophy.
    Landfeldt E; Lindgren P; Bell CF; Schmitt C; Guglieri M; Straub V; Lochmüller H; Bushby K
    J Neuromuscul Dis; 2015; 2(1):63-72. PubMed ID: 26870664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early corticosteroid treatment in 4 Duchenne muscular dystrophy patients: 14-year follow-up.
    Merlini L; Gennari M; Malaspina E; Cecconi I; Armaroli A; Gnudi S; Talim B; Ferlini A; Cicognani A; Franzoni E
    Muscle Nerve; 2012 Jun; 45(6):796-802. PubMed ID: 22581531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asthma care practices, perceptions, and beliefs of Chicago-area asthma specialists. Chicago Asthma Surveillance Initiative Project Team.
    Moy JN; Grant EN; Turner-Roan K; Li T; Weiss KB
    Chest; 1999 Oct; 116(4 Suppl 1):154S-162S. PubMed ID: 10532477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term ventilation for patients with Duchenne muscular dystrophy : physicians' beliefs and practices.
    Gibson B
    Chest; 2001 Mar; 119(3):940-6. PubMed ID: 11243978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics and emerging treatments for Duchenne and Becker muscular dystrophy.
    Wein N; Alfano L; Flanigan KM
    Pediatr Clin North Am; 2015 Jun; 62(3):723-42. PubMed ID: 26022172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of Duchenne muscular dystrophy long-term survivors aged 40 years and older living in specialized institutions in Japan.
    Saito T; Kawai M; Kimura E; Ogata K; Takahashi T; Kobayashi M; Takada H; Kuru S; Mikata T; Matsumura T; Yonemoto N; Fujimura H; Sakoda S
    Neuromuscul Disord; 2017 Feb; 27(2):107-114. PubMed ID: 28003112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.